ID   BT187
AC   CVCL_WW46
SY   BT 187; CPDM_1288X
DR   PharmacoDB; BT187_123_2019
DR   Wikidata; Q93432593
RX   PubMed=25184684;
WW   Provider; CPDM; CPDM_1288X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Low-passage-number culture.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, right temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
RX   PubMed=25184684; DOI=10.1371/journal.pone.0106694; PMCID=PMC4153667;
RA   Holmberg Olausson, Karl
RA   Maire, Cecile L.
RA   Haidar, Samer
RA   Ling, Jason
RA   Learner, Emily
RA   Nister, Monica
RA   Ligon, Keith Lloyd
RT   "Prominin-1 (CD133) defines both stem and non-stem cell populations in
RT   CNS development and gliomas.";
RL   PLoS ONE 9:e106694.1-e106694.11(2014).
//